Cargando…
miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
Liver fibrosis is a common pathological process of end-stage liver diseases. However, the role of microRNA (miRNA) in liver fibrosis is poorly understood. The activated hepatic stellate cells (HSCs) are the major source of fibrogenic cells and play a central role in liver fibrosis. In this study, we...
Autores principales: | Wei, Song, Wang, Qi, Zhou, Haoming, Qiu, Jiannan, Li, Changyong, Shi, Chengyu, Zhou, Shun, Liu, Rui, Lu, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539335/ https://www.ncbi.nlm.nih.gov/pubmed/31150929 http://dx.doi.org/10.1016/j.omtn.2019.05.001 |
Ejemplares similares
-
MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression
por: Wang, Qi, et al.
Publicado: (2020) -
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
por: Qiu, Jiannan, et al.
Publicado: (2022) -
miRNA‐130b‐5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression
por: Wang, Hao, et al.
Publicado: (2021) -
miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis
por: Zhou, Li, et al.
Publicado: (2017) -
β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer
por: Song, Ping, et al.
Publicado: (2020)